New program aims to slash HIV risk in opioid users with rapid access to prevention and treatment

NCT ID NCT05769218

Recruiting now Prevention Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

First seen Apr 08, 2026 · Last updated May 12, 2026 · Updated 6 times

Summary

This study tests a program called CHORUS+ that helps people who inject opioids quickly get HIV prevention medication (PrEP) and addiction treatment (MOUD). Participants receive HIV self-test kits, rapid prescriptions, and 6 months of peer coaching. The goal is to see if this approach increases use of these life-saving medications compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Boston Medical Center Faster Paths Bridge Clinic
RECRUITING

Boston, Massachusetts, 02118, United States
Victory Programs Mobile Prevention Services Van and Navigation Center
RECRUITING

Boston, Massachusetts, 02118, United States

Conditions

Explore the condition pages connected to this study.

OPIOID USE DISORDER